ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Cytotopic Thrombin Inhibition Prior to Cold Ischaemia Attenuates Microvascular Endothelial Ischaemia-Reperfusion Injury.

B. Sandhu,1 M. Prendecki,1 J. Crawley,1 N. Galloway-Phillips,1 N. Vallant,1 J. Mason,1 A. Dorling,2 R. Smith,2 C. Pusey,1 V. Papalois.1

1Imperial College, London, United Kingdom
2King's College, London, United Kingdom

Meeting: 2017 American Transplant Congress

Abstract number: D61

Keywords: Anticoagulation, Endothelial cells, Ischemia

Session Information

Session Name: Poster Session D: Ischemic Injury and Organ Preservation Session III

Session Type: Poster Session

Date: Tuesday, May 2, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Purpose: Microvascular dysfunction post-reperfusion of the ischaemic endothelium manifests as cellular necrosis and enhanced endothelial permeability. Thrombin generation post-reperfusion of the ischaemic endothelium may be implicated in cellular activation and increased permeability due to cytoskeletal derangement. We examined the effect of endothelial pre-treatment with a novel, cytotopic direct thrombin inhibitor (Thrombalexin) on cellular injury.

Methods: Human microvascular endothelial cells were used in an in vitro model of ischaemia-reperfusion injury. Cell monolayers were exposed to hypoxic conditions at 4[deg]C, prior to reperfusion (normoxia, 37[deg]C). Apoptosis and necrosis were assessed using Annexin V/Propidium Iodide staining on flow cytometry. Endothelial permeability post-reperfusion was assessed by measuring Fluorescein isothiocyanate (FITC)-dextran passage through cells seeded on semi-permeable Transwell inserts.

Results: Pre-treatment with Thrombalexin prior to cold storage reduced the percentage of Annexin V/PI positive cells from 3.1% to 2.0% (p=0.0287). Annexin V/PI negative cell percentages increased in Thrombalexin treated cells also (0.47% to 14.4% respectively, p=0.0007). Treatment post cold storage, pre-reperfusion also resulted in a significant reduction in the percentage of Annexin V/PI positive cells from 4.4% to 1.7% (p=0.006). However, treatment at this interval had no significant effect on increasing viable cells (Annexin V/PI negative population, p=0.13) Exposure of the microvascular endothelium to IR resulted in a significant increase in endothelial permeability compared to cells maintained at resting conditions (119 vs. 36 Mean Relative Fluorescence Units respectively, p=<0.0001). Treatment of the endothelium prior to cold ischaemia with Thrombalexin abrogated this effect (IR untreated 119 vs. IR treated 38.5 RFU; p=<0.0001).

Discussion: Pre-treatment with cytotopic thromboregulation effectively protects the microvascular endothelium from deleterious reperfusion injury. The observed difference in treatment pre-reperfusion may be secondary to reduced adherence of the peptide to the injured ischaemic endothelium. This data also implicates thrombin generation post-reperfusion as a significant causative factor in the observed increased endothelial permeability, as direct thrombin inhibition restored permeability to near resting conditions.

CITATION INFORMATION: Sandhu B, Prendecki M, Crawley J, Galloway-Phillips N, Vallant N, Mason J, Dorling A, Smith R, Pusey C, Papalois V. Cytotopic Thrombin Inhibition Prior to Cold Ischaemia Attenuates Microvascular Endothelial Ischaemia-Reperfusion Injury. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Sandhu B, Prendecki M, Crawley J, Galloway-Phillips N, Vallant N, Mason J, Dorling A, Smith R, Pusey C, Papalois V. Cytotopic Thrombin Inhibition Prior to Cold Ischaemia Attenuates Microvascular Endothelial Ischaemia-Reperfusion Injury. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/cytotopic-thrombin-inhibition-prior-to-cold-ischaemia-attenuates-microvascular-endothelial-ischaemia-reperfusion-injury/. Accessed June 1, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences